LENZ Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	35.14	47.73	378.69	19.82	0.01
Short-Term Investments	30.65	220.5	0	0	0
Cash & Cash Equivalents	65.79	268.23	378.69	19.82	0.01
Cash Growth	-75.47%	-29.17%	1810.95%	330183.33%	-
Other Current Assets	1.45	7.14	3.04	1.29	0
Total Current Assets	67.24	275.37	381.74	21.1	0.01
Property, Plant & Equipment	0.37	28.21	18.08	1.46	0
Long-Term Investments	0	17.04	0	0	0
Other Long-Term Assets	2.76	1.29	2.17	0	0
Total Long-Term Assets	3.13	46.54	20.25	1.46	0
Total Assets	70.38	321.9	401.99	22.56	0.01
Accounts Payable	5.71	2.61	2.45	0.63	0
Current Debt	0	4.05	5.48	0	2.21
Other Current Liabilities	12.8	6.39	4.21	31.42	0.02
Total Current Liabilities	18.51	13.04	12.14	32.05	2.22
Long-Term Debt	0.19	1.75	5.79	0	0
Other Long-Term Liabilities	0.99	10.82	0	0.32	0
Total Long-Term Liabilities	1.18	12.57	5.79	0.32	0
Total Liabilities	19.7	25.61	17.94	32.36	2.22
Total Debt	0.19	5.79	11.28	0	2.21
Debt Growth	-96.69%	-48.62%	-	-	-
Retained Earnings	-95.25	-242.4	-141.35	-70.59	-2.22
Comprehensive Income	0.01	-1.05	0	0	0
Shareholders' Equity	-92.71	296.29	384.05	-65.41	-2.22
Net Cash / Debt	65.6	262.44	367.42	19.82	-2.2
Net Cash / Debt Growth	-75.00%	-28.57%	1754.04%	-	-
Net Cash Per Share	8.05	33.48	88.93	60.73	-
Working Capital	48.73	262.32	369.59	-10.95	-2.22
Book Value Per Share	-11.38	37.80	92.96	-200.46	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).